Cargando…

Longitudinal changes in (18)F-Flutemetamol amyloid load in cognitively intact APOE4 carriers versus noncarriers: Methodological considerations

PURPOSE: Measuring longitudinal changes in amyloid load in the asymptomatic stage of Alzheimer’s disease is of high relevance for clinical research and progress towards more efficacious, timely treatments. Apolipoprotein E ε4 (APOE4) has a well-established effect on the rate of amyloid accumulation....

Descripción completa

Detalles Bibliográficos
Autores principales:	Luckett, Emma S., Schaeverbeke, Jolien, De Meyer, Steffi, Adamczuk, Katarzyna, Van Laere, Koen, Dupont, Patrick, Vandenberghe, Rik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850036/ https://www.ncbi.nlm.nih.gov/pubmed/36621019 http://dx.doi.org/10.1016/j.nicl.2023.103321

Ejemplares similares

Longitudinal APOE4- and amyloid-dependent changes in the blood transcriptome in cognitively intact older adults
por: Luckett, Emma S., et al.
Publicado: (2023)

Classification of (18)F-Flutemetamol scans in cognitively normal older adults using machine learning trained with neuropathology as ground truth
por: Reinartz, Mariska, et al.
Publicado: (2022)

Association of Alzheimer’s disease polygenic risk scores with amyloid accumulation in cognitively intact older adults
por: Luckett, Emma S., et al.
Publicado: (2022)

Changes in the language system as amyloid-β accumulates
por: Reinartz, Mariska, et al.
Publicado: (2021)

Baseline cognition is the best predictor of 4-year cognitive change in cognitively intact older adults
por: Schaeverbeke, Jolien M., et al.
Publicado: (2021)

Lack of association between bridging integrator 1 (BIN1) rs744373 polymorphism and tau‐PET load in cognitively intact older adults
por: Schaeverbeke, Jolien, et al.
Publicado: (2022)

Polymorphism of brain derived neurotrophic factor influences β amyloid load in cognitively intact apolipoprotein E ε4 carriers()
por: Adamczuk, Katarzyna, et al.
Publicado: (2013)

Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease()
por: Vandenberghe, Rik, et al.
Publicado: (2013)

Phospho‐specific plasma p‐tau181 assay detects clinical as well as asymptomatic Alzheimer's disease
por: De Meyer, Steffi, et al.
Publicado: (2022)

Prognostic value of amyloid/tau/neurodegeneration (ATN) classification based on diagnostic cerebrospinal fluid samples for Alzheimer’s disease
por: Delmotte, Koen, et al.
Publicado: (2021)

Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease
por: Adamczuk, Katarzyna, et al.
Publicado: (2015)

Amnestic MCI Patients’ Perspectives toward Disclosure of Amyloid PET Results in a Research Context
por: Vanderschaeghe, Gwendolien, et al.
Publicado: (2017)

Amnestic MCI patients’ experiences after disclosure of their amyloid PET result in a research context
por: Vanderschaeghe, Gwendolien, et al.
Publicado: (2017)

From information to follow-up: Ethical recommendations to facilitate the disclosure of amyloid PET scan results in a research setting
por: Vanderschaeghe, Gwendolien, et al.
Publicado: (2018)

Serum neurofilament heavy chains as early marker of motor neuron degeneration
por: De Schaepdryver, Maxim, et al.
Publicado: (2019)

Nasal microbiome disruption and recovery after mupirocin treatment in Staphylococcus aureus carriers and noncarriers
por: Baede, Valérie O., et al.
Publicado: (2022)

Cholinergic depletion and basal forebrain volume in primary progressive aphasia
por: Schaeverbeke, Jolien, et al.
Publicado: (2016)

Distinct [(18)F]THK5351 binding patterns in primary progressive aphasia variants
por: Schaeverbeke, Jolien, et al.
Publicado: (2018)

Reproducibility of graph measures at the subject level using resting‐state fMRI
por: Ran, Qian, et al.
Publicado: (2020)

Posterior Intraparietal Sulcus Mediates Detection of Salient Stimuli Outside the Endogenous Focus of Attention
por: Jamoulle, Tarik, et al.
Publicado: (2021)

Reduction in the number of CGG repeats on the FMR1 gene in carriers of genetic disorders versus noncarriers
por: Peyser, Alexandra, et al.
Publicado: (2017)

Binding of [(18)F]AV1451 in post mortem brain slices of semantic variant primary progressive aphasia patients
por: Schaeverbeke, Jolien, et al.
Publicado: (2019)

P53 mutations in breast and ovarian carcinomas from BRCA1 and 2 mutation carriers and noncarriers
por: Sensi, E, et al.
Publicado: (2000)

Theoretical Study of LED Operating in Noncarrier Injection Mode
por: Wu, Chaoxing, et al.
Publicado: (2022)

A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers
por: Kadouri, L, et al.
Publicado: (2004)

Amyloid-Targeting PET Tracer [(18)F]Flutemetamol Accumulates in Atherosclerotic Plaques
por: Hellberg, Sanna, et al.
Publicado: (2019)

Environmental Contaminants Modulate Breast Cancer Development and Outcome in TP53 p.R337H Carriers and Noncarriers
por: Gerber, Viviane K. Q., et al.
Publicado: (2022)

Clinical significance of focal ß-amyloid deposition measured by (18)F-flutemetamol PET
por: Kim, Si Eun, et al.
Publicado: (2020)

Estimation of amyloid distribution by [(18)F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition
por: Thal, Dietmar Rudolf, et al.
Publicado: (2018)

Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis
por: De Meyer, Steffi, et al.
Publicado: (2020)

Single-word comprehension deficits in the nonfluent variant of primary progressive aphasia
por: Schaeverbeke, Jolien, et al.
Publicado: (2018)

Clinical outcomes up to 9 years after [(18)F]flutemetamol amyloid-PET in a symptomatic memory clinic population
por: Collij, Lyduine E., et al.
Publicado: (2023)

Effect of physical exercise on cognitive function in older adults’ carriers versus noncarriers of apolipoprotein E4: systematic review and meta-analysis
por: Cancela-Carral, José María, et al.
Publicado: (2021)

Centiloid scaling for quantification of brain amyloid with [(18)F]flutemetamol using multiple processing methods
por: Battle, Mark R., et al.
Publicado: (2018)

Is Amyloid Burden Measured by (18)F-Flutemetamol PET Associated with Progression in Clinical Alzheimer’s Disease?
por: Müller, Ebba Gløersen, et al.
Publicado: (2022)

Structural brain volume differences between cognitively intact ApoE4 carriers and non-carriers across the lifespan
por: Piers, Ryan J.
Publicado: (2018)

Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection
por: Ikonomovic, Milos D., et al.
Publicado: (2016)

Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [(18)F]-Flutemetamol PET Scan Result
por: Westwood, Sarah, et al.
Publicado: (2018)

Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer’s disease
por: Ikonomovic, Milos D., et al.
Publicado: (2020)

Performance of [(18)F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's disease
por: Salloway, Stephen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8kh8ctrnejcflv3267dnesm5mm